SupportNotes 05349 · Member profile
Case 22 — Review moderation: evidence without doxxing Limit of the answer in “Review moderation: evidence without doxxing”: “Keep original records pri…
Case 4 — Recall notices: verify the product and jurisdiction Clarification for “Recall notices: verify the product and jurisdiction”: the point beginn…
Method note for “Review moderation: evidence without doxxing”: use “Keep original records privately, redact personal information in public…” as a row …
For a support screenshot, remove other people’s details as well as your own. Summarise irrelevant portions instead of uploading an entire conversation…
Case 46 — Dispatch email versus carrier acceptance: how should the timeline read? · source wording exercise Correction note for “Dispatch email versus…
Case 175 — Price comparisons: compare like-for-like information · reader check exercise Correction note for “Price comparisons: compare like-for-like …
Case 47 — A source review checklist that separates evidence from reassurance · source wording exercise Correction note for “A source review checklist …
Keep the product and supplied leaflet and describe the duration and conditions of exposure. Ask a pharmacist or the manufacturer about the specific pr…
Case 11 — Delivery feedback is not a medicine-quality assessment A review only documents delivery speed. How should its scope be stated? Exercise PHAR…
Method note for “Recall notices: verify the product and jurisdiction”: use “Use the official regulator or manufacturer notice and…” as a row heading i…
Remove names, addresses, prescription identifiers, contact details, account references, tracking tokens and scannable codes from the public copy. Keep…
Case 26 — Reporting a suspected adverse reaction · source wording exercise Limit of the answer in “Reporting a suspected adverse reaction”: “Seek appr…
Case 36 — Redacting a review: which details should stay private? · source wording exercise A draft review includes a shipping label, a medicine label …
Reader check for “Preparing a useful question for a pharmacist”: distinguish the discussion point “This forum template cannot determine interactions…”…